📰 2 sources covering this story

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

First covered 20 hrs ago · latest take 42 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
STAT News
STAT News42 mins ago
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer
Quartz
Quartz🏁 first to report20 hrs ago
Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals
A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →